0,936  0,002  NOS3 expression inhibitor
0,935  0,003  TNF expression inhibitor
0,923  0,003  CYP2C19 substrate
0,910  0,003  UDP-glucuronosyltransferase substrate
0,906  0,004  CYP2C9 substrate
0,888  0,004  Teratogen
0,883  0,005  Embryotoxic
0,865  0,002  Anesthetic general
0,855  0,001  UGT1A4 substrate
0,857  0,006  CYP3A4 substrate
0,845  0,003  Sulfotransferase substrate
0,837  0,003  Endometrios treatment
0,810  0,002  Androgen antagonist
0,815  0,013  Antiinflammatory
0,791  0,003  Prostatic (benign) hyperplasia treatment
0,789  0,005  CYP1A2 substrate
0,778  0,003  Diuretic
0,776  0,007  Respiratory analeptic
0,771  0,003  Anesthetic
0,769  0,005  Antiepileptic
0,772  0,008  Carcinogenic
0,765  0,003  Hair growth stimulant
0,766  0,005  CYP2D6 substrate
0,745  0,001  Aldosterone antagonist
0,747  0,016  Transcription factor NF kappa B inhibitor
0,732  0,006  Cholesterol antagonist
0,731  0,006  Bone diseases treatment
0,720  0,004  Growth factor agonist
0,719  0,005  Antiosteoporotic
0,716  0,009  Antihypercholesterolemic
0,704  0,002  Contraceptive
0,707  0,006  Cardiovascular analeptic
0,710  0,008  Sensitization
0,704  0,003  Antipruritic, allergic
0,725  0,027  Apoptosis agonist
0,695  0,002  UGT2B4 substrate
0,694  0,002  Progesterone antagonist
0,694  0,003  Antialcoholic
0,694  0,003  NOS3 expression enhancer
0,690  0,001  Contraceptive female
0,695  0,010  Prostate cancer treatment
0,683  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,677  0,003  Antiacne
0,673  0,001  UGT2B7 substrate
0,670  0,002  Aromatase inhibitor
0,669  0,001  Glucose-6-phosphate dehydrogenase inhibitor
0,667  0,008  UGT1A9 substrate
0,663  0,008  Proliferative diseases treatment
0,659  0,010  Analeptic
0,648  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,662  0,026  Antineoplastic (breast cancer)
0,646  0,014  Mood disorders treatment
0,637  0,006  CYP2C19 inhibitor
0,630  0,003  UGT2B15 substrate
0,628  0,005  Antineoplastic enhancer
0,622  0,002  Prostate disorders treatment
0,624  0,005  Sedative
0,619  0,001  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,614  0,002  Abortion inducer
0,643  0,031  Caspase 9 stimulant
0,605  0,001  5-Alpha-reductase 1 inhibitor
0,614  0,012  CTGF expression inhibitor
0,588  0,002  Lipocortins synthesis antagonist
0,595  0,011  AR expression inhibitor
0,582  0,003  Autism spectrum disorders treatment
0,591  0,014  Chemopreventive
0,579  0,004  UGT2B1 substrate
0,576  0,002  Cushing's syndrome treatment
0,569  0,001  5-Alpha-reductase 2 inhibitor
0,561  0,002  Menstruation disorders treatment
0,562  0,004  Psychosexual dysfunction treatment
0,560  0,003  Antiinfertility, female
0,560  0,004  Muscular dystrophy treatment
0,558  0,003  Contraceptive male
0,557  0,002  UGT2B9 substrate
0,554  0,001  5-Alpha-reductase inhibitor
0,565  0,013  NOS2 expression inhibitor
0,556  0,004  Aldehyde dehydrogenase inhibitor
0,534  0,003  Postmenopausal disorders treatment
0,527  0,002  Antipruritic, non-allergic
0,545  0,022  Immunosuppressant
0,521  0,005  Interferon gamma antagonist
0,516  0,003  Mineralocorticoid receptor antagonist
0,515  0,007  P-glycoprotein inhibitor
0,508  0,004  Neurotrophic factor enhancer
0,503  0,004  Sodium/bile acid cotransporter inhibitor
0,506  0,012  UGT1A6 substrate
0,498  0,007  Sleep disorders treatment
0,486  0,001  UGT2B10 substrate
0,482  0,003  Posttraumatic stress disorder treatment
0,496  0,023  Hepatic disorders treatment
0,475  0,002  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,450  0,003  LDLR expression enhancer
0,467  0,025  Apoptosis antagonist
0,473  0,033  Antiallergic
0,458  0,018  CYP3A4 inhibitor
0,458  0,019  Nitric oxide antagonist
0,454  0,016  Eye irritation, high
0,436  0,000  UGT2B11 substrate
0,452  0,019  Cardiodepressant
0,448  0,016  Interleukin 2 agonist
0,460  0,033  Antineoplastic (ovarian cancer)
0,434  0,014  UGT1A1 substrate
0,449  0,031  Antineoplastic (melanoma)
0,427  0,019  Antineoplastic (liver cancer)
0,413  0,013  Muscle relaxant
0,398  0,001  RNA-directed RNA polymerase stimulant
0,410  0,020  Myocardial infarction treatment
0,387  0,004  Estrogen receptor alpha antagonist
0,429  0,046  Stroke treatment
0,385  0,005  Cholesterol synthesis inhibitor
0,413  0,033  Antineoplastic (glioma)
0,417  0,042  Antidepressant
0,409  0,035  Cytotoxic
0,402  0,030  Mutagenic
0,371  0,003  Estradiol 17 beta-dehydrogenase inhibitor
0,371  0,005  Estrogen antagonist
0,368  0,001  Progesterone agonist
0,366  0,000  Transcortin receptor antagonist
0,351  0,002  Premenstrual syndrome treatment
0,356  0,009  Antipruritic
0,349  0,004  Farnesoid X receptor antagonist
0,345  0,004  Alcohol dehydrogenase substrate
0,397  0,059  CYP2C9 inhibitor
0,339  0,003  Androgen agonist
0,378  0,044  Antineoplastic (pancreatic cancer)
0,341  0,007  Antifungal enhancer
0,333  0,002  Glucocorticoid antagonist
0,335  0,009  Toxic, respiratory center
0,324  0,001  Arachidonic acid antagonist
0,338  0,016  Skeletal muscle relaxant
0,324  0,002  Glycine receptor agonist
0,342  0,020  Hepatoprotectant
0,355  0,035  Antineoplastic (glioblastoma multiforme)
0,357  0,039  Antiprotozoal (Leishmania)
0,315  0,002  Glycine receptor antagonist
0,353  0,041  Huntington's disease treatment
0,316  0,005  Estrogen agonist
0,324  0,018  UGT1A3 substrate
0,343  0,038  Antineoplastic (renal cancer)
0,308  0,004  GABA receptor antagonist
0,360  0,057  ICAM1 expression inhibitor
0,333  0,034  Interleukin agonist
0,298  0,006  GABA receptor agonist
0,290  0,005  Hedgehog signaling inhibitor
0,286  0,004  Pregnane X receptor agonist
0,321  0,042  Angiogenesis stimulant
0,307  0,034  Antiparkinsonian, rigidity relieving
0,288  0,023  Melanin inhibitor
0,271  0,008  VEGF expression inhibitor
0,268  0,004  GABA A receptor antagonist
0,344  0,081  Cognition disorders treatment
0,267  0,005  GABA A receptor agonist
0,313  0,053  Chemoprotective
0,320  0,061  Aldehyde oxidase inhibitor
0,267  0,009  Antieczematic
0,302  0,044  5 Hydroxytryptamine uptake stimulant
0,266  0,008  SULT1A1 substrate
0,260  0,003  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,305  0,051  Cytostatic
0,314  0,059  Antineoplastic (endocrine cancer)
0,297  0,043  Psychostimulant
0,325  0,072  Immunostimulant
0,315  0,063  Lipoprotein disorders treatment
0,354  0,102  Antiparkinsonian
0,306  0,055  Antipyretic
0,251  0,002  Postcoital contraceptive
0,257  0,008  Choleretic
0,250  0,003  Antihyperaldosteronism
0,252  0,006  Growth stimulant
0,247  0,004  Tocolytic
0,285  0,043  Antihypertriglyceridemic
0,292  0,051  Acute neurologic disorders treatment
0,270  0,031  Diabetic retinopathy treatment
0,242  0,004  Bile acid receptor antagonist
0,239  0,002  Anabolic
0,243  0,009  Antineoplastic, alkylator
0,307  0,075  Antineoplastic (brain cancer)
0,279  0,049  Gastrin inhibitor
0,289  0,060  Antineoplastic (cervical cancer)
0,250  0,023  Interleukin 6 antagonist
0,245  0,018  DNA polymerase I inhibitor
0,234  0,007  Estrogen receptor beta antagonist
0,324  0,101  Antiobesity
0,239  0,020  Antihyperlipoproteinemic
0,295  0,076  Metabolic disease treatment
0,311  0,094  Antineoplastic (lung cancer)
0,221  0,005  Dysmenorrhea treatment
0,223  0,007  Actinic keratosis treatment
0,312  0,097  Antileukemic
0,237  0,029  Age-related macular degeneration treatment
0,213  0,004  Estrogen receptor alpha agonist
0,271  0,063  Vascular (periferal) disease treatment
0,218  0,014  Anticataract
0,269  0,065  Antidiabetic symptomatic
0,250  0,046  Antiviral (Influenza)
0,288  0,086  Antifungal
0,253  0,053  Antihypotensive
0,230  0,031  Antiviral (Influenza A)
0,196  0,002  Glucocorticoid agonist
0,203  0,010  AMP-activated protein kinase stimulant
0,195  0,005  Estrogen receptor beta agonist
0,194  0,005  Acetylcholine release stimulant
0,221  0,034  Lipid peroxidase inhibitor
0,273  0,093  Antineoplastic (osteosarcoma)
0,260  0,080  Transcription factor STAT inhibitor
0,182  0,003  Na+ K+ transporting ATPase inhibitor
0,207  0,031  Phobic disorders treatment
0,209  0,035  Carcinogenic, group 3
0,319  0,147  Cyclophilin D inhibitor
0,319  0,147  Antidiabetic
0,250  0,080  DNA damaging
0,250  0,084  Antioxidant
0,170  0,005  Anticholelithogenic
0,196  0,033  Anesthetic local
0,189  0,028  Adenylate cyclase inhibitor
0,252  0,091  Radioprotector
0,161  0,003  Estrone sulfatase inhibitor
0,200  0,044  Phospholipase C inhibitor
0,156  0,002  Lipocortins synthesis agonist
0,224  0,070  RNA-directed DNA polymerase inhibitor
0,157  0,003  Anesthetic inhalation
0,248  0,101  GST M1-1 substrate
0,160  0,015  ABCA1 expression enhancer
0,254  0,112  Immunomodulator
0,160  0,018  Acetylcholine nicotinic antagonist
0,245  0,104  Antihypoxic
0,169  0,030  Liver cirrhosis treatment
0,177  0,039  Monophenol monooxygenase inhibitor
0,188  0,054  Antirickettsial
0,165  0,031  Microtubule formation inhibitor
0,210  0,077  VCAM1 expression inhibitor
0,183  0,050  Amylase inhibitor
0,169  0,036  Retinoprotector
0,134  0,001  Corticosteroid-like
0,144  0,014  CDC25A inhibitor
0,147  0,017  Inducible nitric-oxide synthase inhibitor
0,165  0,036  Antihemorrhagic
0,131  0,004  Andropause treatment
0,198  0,074  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,128  0,008  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,123  0,003  Hypogonadism treatment
0,165  0,046  Movement disorders treatment
0,120  0,001  Progesterone receptor A antagonist
0,120  0,003  Pregnane X receptor antagonist
0,218  0,101  Antineoplastic (sarcoma)
0,168  0,053  Genotoxic
0,203  0,091  Hypolipemic
0,230  0,118  Antipsoriatic
0,161  0,050  Neurotrophic factor
0,114  0,003  GABA uptake inhibitor
0,192  0,082  Pneumotoxic
0,171  0,063  Antiviral (Herpes)
0,238  0,131  Antihypertensive
0,145  0,041  Carcinogenic, group 2B
0,124  0,020  Keratolytic
0,127  0,025  Tourette's syndrome treatment
0,178  0,076  Diabetic nephropathy treatment
0,108  0,006  SULT2A1 substrate
0,204  0,106  Tumour necrosis factor alpha release inhibitor
0,147  0,048  Skin irritative effect
0,142  0,044  Glutathione S-transferase substrate
0,124  0,027  SULT1E1 substrate
0,098  0,008  Heme oxygenase stimulant
0,107  0,019  Narcotic antagonist
0,207  0,121  Amyotrophic lateral sclerosis treatment
0,224  0,138  Caspase 3 stimulant
0,156  0,073  Antimutagenic
0,258  0,176  Analgesic
0,119  0,039  Prolactin inhibitor
0,210  0,131  Anxiolytic
0,127  0,053  Interleukin 8 antagonist
0,081  0,007  Liver X receptor alpha agonist
0,081  0,010  Liver X receptor agonist
0,177  0,106  Dependence treatment
0,076  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,208  0,138  Antineoplastic (multiple myeloma)
0,115  0,048  Toll-Like receptor 4 antagonist
0,143  0,076  Adenylate cyclase stimulant
0,105  0,039  Ornithine decarboxylase inhibitor
0,264  0,201  Alzheimer's disease treatment
0,126  0,063  Alkylator
0,138  0,082  Ca2+-transporting ATPase inhibitor
0,149  0,094  Male reproductive disfunction treatment
0,154  0,101  Platelet adhesion inhibitor
0,099  0,047  Antineoplastic antibiotic
0,067  0,017  Potassium channel Kv1.3 blocker
0,116  0,068  Transcription factor STAT6 inhibitor
0,074  0,026  Hypercalcemia treatment
0,127  0,079  Bone formation stimulant
0,089  0,042  Estrogen-related receptor beta agonist
0,050  0,003  Hedgehog signaling activator
0,047  0,001  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,057  0,014  Parathyroid hormone antagonist
0,189  0,147  Renal disease treatment
0,050  0,010  Liver X receptor beta agonist
0,132  0,093  Acetylcholine M1 receptor antagonist
0,052  0,013  Farnesoid X receptor agonist
0,049  0,011  Cholesterol absorption inhibitor
0,135  0,097  Sigma receptor agonist
0,179  0,142  5 Hydroxytryptamine release stimulant
0,121  0,084  Skin whitener
0,085  0,051  Opioid kappa receptor antagonist
0,086  0,052  Antiprotozoal activity enhancer
0,163  0,130  Free radical scavenger
0,038  0,005  Vitamin D receptor antagonist
0,087  0,055  Transcription factor NF kappa B stimulant
0,182  0,150  DNA synthesis inhibitor
0,078  0,048  SULT1A2 substrate
0,217  0,189  Calcium channel activator
0,052  0,025  Microtubule stabilization
0,065  0,039  Antimycoplasmal
0,116  0,091  Cocaine dependence treatment
0,104  0,079  Antiviral (Coronavirus)
0,104  0,079  Antiviral (SARS coronavirus)
0,112  0,089  Coagulant
0,060  0,039  Gonadotropin-releasing hormone receptor agonist
0,046  0,027  Opioid kappa receptor agonist
0,181  0,162  Transcription factor STAT3 inhibitor
0,116  0,098  Antineoplastic (carcinoma)
0,024  0,008  Progesterone receptor B antagonist
0,105  0,091  Bipolar disorder treatment
0,079  0,065  Sleep apnea treatment
0,103  0,089  Acetylcholine antagonist
0,205  0,191  Inflammatory Bowel disease treatment
0,026  0,013  CYP24 inhibitor
0,103  0,091  Cholinergic antagonist
0,019  0,007  Vitamin D receptor agonist
0,112  0,101  Protein kinase stimulant
0,112  0,101  Antiprotozoal (Trichomonas)
0,084  0,073  Paget's disease treatment
0,168  0,161  Antineoplastic (colorectal cancer)
0,077  0,070  Antineoplastic alkaloid
0,017  0,011  Telomerase stimulant
0,163  0,160  Cardiotonic
0,148  0,148  Antineoplastic (lymphoma)

